Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.

Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc. SOMERSET, N.J., August 14, 2018 – Catalent, Inc. (NYSE: CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the successful completion of the previously announced tender offer by Catalent Boston, […]

Read More

CERTIS ONCOLOGY PARTNERS WITH REVEAL BIOSCIENCES TO OFFER ADVANCED PRE-CLINICAL ONCOLOGY SERVICES

CERTIS ONCOLOGY PARTNERS WITH REVEAL BIOSCIENCES TO OFFER ADVANCED PRE-CLINICAL ONCOLOGY SERVICES   SAN DIEGO, AUGUST 13, 2018. Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation suite of pre-clinical oncology services.   Under the agreement, Reveal will leverage its Artificial […]

Read More

FROM BENCH TO BEDSIDE – THE POTENTIAL OF REGENERATIVE MEDICINE

FROM BENCH TO BEDSIDE – THE POTENTIAL OF REGENERATIVE MEDICINE July 24, 2018 What if a patient could use her own cells to treat her disease? Bench-to-bedside therapeutics are possible with cell and gene therapies, and there has been steady growth in these industries over the past few years. According to the Alliance of Regenerative […]

Read More

Ask DEL BioPharma LLC: Selecting a CRO/CMO involves multiple considerations that are applicable to any component of the drug discovery/development process.  From the perspective of API manufacturing, it is critical to understand the following:

A company is looking to build a partnership with a CRO for the development of a new drug. This decision is a complex one and can play a significant role in the success for the company. What are the top 3 considerations that the company must make in their selection process to ensure that they […]

Read More

Bead-beating tissue homogenisation technology – a powerful and high throughput sample prep tool for quantitation of analyte in bone, skin & lymph node

Bead-beating tissue homogenisation technology – a powerful and high throughput sample prep tool for quantitation of analyte in bone, skin & lymph node Bhavesh Patel, Director – Head DMPK-Bioanalysis, Eurofins Advinus Limited, BhaveshPatel3@eurofins.com Estimation of drug concentrations in tough tissues such as skin, lymph nodes, ocular tissues and bones is critical for many preclinical pharmacokinetic studies. For […]

Read More

Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc. $133 Million Deal Adds European Early Development Center of Excellence to Global Network   SOMERSET, N.J., July 3, 2018 – Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has […]

Read More